| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/17/2003 | EP1370298A1 Elongated and multiple spacers in activatible prodrugs |
| 12/17/2003 | EP1370290A2 Molecular antigen array |
| 12/17/2003 | EP1370287A2 Method and composition for modulating bone growth |
| 12/17/2003 | EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 12/17/2003 | EP1370283A2 Prevention of recurrent viral disease |
| 12/17/2003 | EP1370282A2 Method for treating ischemic events affecting the central nervous system |
| 12/17/2003 | EP1157031B1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers |
| 12/17/2003 | EP1028715B1 Dosage composition for nasal delivery comprising vibrio cholera zonula occludens toxin as absorption enhancer |
| 12/17/2003 | EP1009420B1 Conjugates useful in the treatment of prostate cancer |
| 12/17/2003 | EP1007074B1 Hypothalamus-specific polypeptides |
| 12/17/2003 | EP0956349B1 Synthetic hpv16 virus-like particles |
| 12/17/2003 | EP0954580B1 Human sdf-5 protein and compositions |
| 12/17/2003 | EP0922101B1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 12/17/2003 | EP0917580B1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS |
| 12/17/2003 | EP0835310B1 Regulatory elements conferring tapetum specificity |
| 12/17/2003 | EP0795005B1 New e.coli mutant with suppressed organic acid production |
| 12/17/2003 | EP0792363B1 Novel pesticidal proteins and strains |
| 12/17/2003 | EP0733063B1 Compositions and kits for fluorescence polarization assay of large molecules |
| 12/17/2003 | EP0706570B1 Plants having modified response to ethylene |
| 12/17/2003 | EP0672131B1 A novel cell cycle control protein |
| 12/17/2003 | EP0669984B1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 12/17/2003 | EP0650523B1 RECOMBINANT CDw52 ANTIGEN |
| 12/17/2003 | EP0571387B1 A non-mitogenic competitive hgf antagonist |
| 12/17/2003 | EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 12/17/2003 | EP0536352B1 Therapeutic and preventive vaccines for hiv |
| 12/17/2003 | EP0527753B2 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 12/17/2003 | EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor |
| 12/17/2003 | CN1462309A Codon-optimized papilloma virus sequences |
| 12/17/2003 | CN1462308A Nucleotide sequences which code lysRs gene |
| 12/17/2003 | CN1462276A Peptide-based compounds |
| 12/17/2003 | CN1462176A Method for generation of high yield, super-productive transgenic plants disturbed in Ran/Ran-binding proteins-mediated cellular process |
| 12/17/2003 | CN1461752A Humon leukemia related reverse transcrigt virus genome coded protein and polypeptide sequence and its application |
| 12/17/2003 | CN1131313C Promoters for gene expression |
| 12/17/2003 | CN1131312C N-teminally extended proteins expressed in yeast |
| 12/17/2003 | CN1131309C IL-6 mutein |
| 12/17/2003 | CN1131240C Chromosome 21 gene marker, compositions and methods using same |
| 12/17/2003 | CN1131070C Method for removal virus A. and pharmacal composite for treating disease caused by virus a. |
| 12/16/2003 | US6664447 Tomato gene.Sw-5 conferring resistance to Tospoviruses |
| 12/16/2003 | US6664446 Recombinant polynucleotides and methods for altering the regulation of gene expression in plants are provided to modify plant's traits, in particular disease tolerance |
| 12/16/2003 | US6664444 1-SST (sucrose:sucrose 1-fructosyl-transferase) enzyme encoding cDNA sequence; transformation; highly linear polysaccharide chains; use in food, feed and beverages |
| 12/16/2003 | US6664443 Pathogenic Tau mutations in transgenic mice |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6664383 Polypeptides, cDNA encoding the same and utilization thereof |
| 12/16/2003 | US6664378 Use of kits containing an antibody binding a specific urogenital carcinoma tumor liberated protein (TLP) epitope for identifying TLP and for diagnosing urogenital carcinoma. |
| 12/16/2003 | US6664377 Use of polypeptides comprising a portion of a prostate tumor protein and to polynucleotide molecules encoding such poly-peptides and kits containing vaccines and pharmaceutical compositions for treatment of prostate cancer |
| 12/16/2003 | US6664376 Chimeric polypeptide molecules |
| 12/16/2003 | US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders |
| 12/16/2003 | US6664374 Polypeptides comprising IL-6 ligand-binding receptor domains |
| 12/16/2003 | US6664373 TWIK-5 potassium channel polypeptides and uses therefor |
| 12/16/2003 | US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 12/16/2003 | US6664368 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 12/16/2003 | US6664367 Cyclic peptides containing modified disulfide bonds coupled with a chelating agent capable of complexing with diagnostic and therapeutically useful metal ions, antineoplastic agents, enzymes, coenzymes or toxins |
| 12/16/2003 | US6664232 HLA-A2 restraint tumor antigen peptide originating in SART-1 |
| 12/16/2003 | US6664231 Based on Domain III (amino acids 142-169) of bactericidal/ permeability-increasing protein; candida, aspergillus, cryptococcus |
| 12/16/2003 | US6664230 Orally administered peptides to ameliorate atherosclerosis |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664107 Insertion of exogenous DNA into genome of mammals producing transgenic mammals with decreased/suppressed endogenous gene expression and/or with expression of a novel gene(s); use in screening drugs for immunostimulatory effects |
| 12/16/2003 | US6664098 Cellular differentiation and proliferation; ligands, membrane receptors; antigrowth agents; use of human Notch ligand, human Delta molecule, in development of drug candidates for differential regulation of undifferentiated cells |
| 12/16/2003 | US6664096 Nutrient broths for use in the propagation of microorganism |
| 12/16/2003 | US6664094 Use of mutants of Neisseria gonorrhoeae in vaccine production which contain mutations in a major outer membrane protein gene such that no immunologically functional polypeptides encoded by said gene are produced |
| 12/16/2003 | US6664077 DNA encoding ACPL |
| 12/16/2003 | US6664075 Polypeptide binds to patched protein; genetic engineering |
| 12/16/2003 | US6664068 Antibodies, antiapoptotic agents |
| 12/16/2003 | US6664066 Modified Morbillivirus V proteins |
| 12/16/2003 | US6664054 Enhancing the expression of down-regulated polynucleotides or introducing down-regulated polypeptide or protein to cell can decrease the growth and/or abnormal characteristics of cancer and dysplasia |
| 12/16/2003 | US6664052 Genetic polymorphism in a complement receptor |
| 12/16/2003 | US6664050 Assaying a sample using an antibody specific to an adenovirus type 36p to test for the presence of the adenovirus; thus testing whether the person has been or is infected with adenovirus type 36p |
| 12/16/2003 | US6664045 PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms |
| 12/16/2003 | US6664041 Method for preparing a viral extract containing HIV-II RNA |
| 12/16/2003 | US6664040 Complexing to polypeptides; antiproliferation agent |
| 12/16/2003 | US6663899 Controlled release microencapsulated NGF formulation |
| 12/16/2003 | US6663872 Immune response |
| 12/16/2003 | US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria |
| 12/16/2003 | US6663870 Methods for promoting growth of bone using zvegf3 |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6663867 Administering to a patient a hybrid protein comprising two different coexpressed amino acid sequences forming heterodimer, each comprising an amino acid sequence of tumor nacrosis factor binding protein and a subunit of hCG, FSG, LH |
| 12/16/2003 | US6663865 Tumor necrosis factor antagonists and their use in endometriosis |
| 12/16/2003 | US6663862 Separation of Fc fragments and Fab fragments of a human IgG. |
| 12/16/2003 | US6663856 Gene therapy |
| 12/16/2003 | CA2096604C Protein c derivatives |
| 12/16/2003 | CA2072627C Recombinant herpes simplex viruses vaccines and methods |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003102592A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 12/11/2003 | WO2003102584A2 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | WO2003102583A1 Targeted therapeutic proteins |
| 12/11/2003 | WO2003102576A1 POLYUBIQUITINATION OF RB CATALYZED BY Mdm2 |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102199A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate |
| 12/11/2003 | WO2003102191A1 Immunogenic sequences |
| 12/11/2003 | WO2003102190A2 Bacterial polypeptides involved in viability |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102186A1 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
| 12/11/2003 | WO2003102182A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 12/11/2003 | WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY |
| 12/11/2003 | WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION |
| 12/11/2003 | WO2003102173A2 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |